Serum chromogranin A in the control of patients on long-term treatment with inhibitors of acid secretion.
about
Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections.Expression of neuroendocrine markers in non-small cell lung cancer.Rebound acid hypersecretion after long-term inhibition of gastric acid secretion.Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.
P2860
Serum chromogranin A in the control of patients on long-term treatment with inhibitors of acid secretion.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@ast
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@en
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@nl
type
label
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@ast
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@en
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@nl
prefLabel
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@ast
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@en
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@nl
P2860
P1476
Serum chromogranin A in the co ...... inhibitors of acid secretion.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2362.2001.00889.X
P577
2001-09-01T00:00:00Z